ReviewFrontiers in neurology
Oxidized lipids as molecular biomarkers in carotid in-stent restenosis: mechanisms and clinical implications.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carotid artery stenting (CAS) has emerged as an effective alternative to carotid endarterectomy for treating carotid artery stenosis, particularly in high-risk surgical patients. However, in-stent restenosis (ISR) remains a significant complication, occurring in 10-30% of patients within the first year after CAS and substantially impacting long-term clinical outcomes. The pathophysiology of ISR involves complex molecular cascades, with oxidative stress and lipid peroxidation playing pivotal roles in neointimal hyperplasia and vascular remodeling. This review provides a comprehensive analysis of oxidized lipids in carotid ISR, focusing on their molecular mechanisms of action and potential as clinical biomarkers. We examine the biochemical pathways leading to lipid oxidation following stent implantation, dissect the molecular mechanisms through which oxidized lipids promote vascular pathology, and evaluate emerging therapeutic strategies. Understanding oxidized lipid pathophysiology offers opportunities for improved risk stratification and targeted therapeutic interventions. Future research should focus on validating specific oxidized lipid biomarkers and developing therapeutic strategies targeting oxidized lipid pathways to prevent ISR and improve patient outcomes following carotid artery stenting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.